HIV-negative trial: Results of cost-effectiveness analysis (per 1000 pregnant HIV-negative women).

All monetary values are expressed in US$ 2012IPTp = Intermittent Preventive Treatment of malaria in pregnancy; HIV = Human Immunodeficiency VirusMQ = Mefloquine; SP = Sulphadoxine-Phyrimethamine; DALY = Disability-adjusted Life Year.*Incremental net costs are equal Incremental cost minus Health system treatment savings**Net incremental costs per DALY averted are equal Incremental net costs divided by number of DALYs avertedHIV-negative trial: Results of cost-effectiveness analysis (per 1000 pregnant HIV-negative women).